Acurx Pharmaceuticals financials at a glance
| Year | Year | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-1.12 | $-1.15 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 |
| Sha. | Shares |
|
10.22m | 10.26m | 0m | 15.82m |
| OCF | Operating Cash Flow |
|
$-5.01M | $-7.54M | $-9.80M | $0.00M |
| FCF | Free Cash Flow |
|
$-12.67M | $0.00M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.59 | $-0.70 | $-0.77 | $0.00 |